Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 16, Issue 3, Pages 157-158
http://dx.doi.org/10.1155/2011/434298
Commentary

Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: Implications for Pain Physicians

Meldon Kahan,1 Angela Mailis-Gagnon,2 and Eldon Tunks3

1Department of Family Medicine, University of Toronto; Addiction Medicine Service, Department of Family Medicine, St Joseph’s Health Centre, Canada
2Department of Medicine, Division of Physiatry, Institute of Medical Science, University of Toronto; Comprehensive Pain Program, Toronto Western Hospital; ACTION Ontario, Centre for the Study of Pain, Toronto, Canada
3Department of Psychiatry, McMaster University, Hamilton; Canadian Memorial Chiropractic College, Toronto, Ontario, Canada

Copyright © 2011 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Chin-Yee Kok, Bi-Li Chen, and Shu-Chen Chien, “A Drug Utility Analysis of the Withdrawal of the Propoxyphene–acetaminophen Combination from a Teaching Hospital in Taiwan,” Journal of Experimental & Clinical Medicine, vol. 4, no. 4, pp. 260–263, 2012. View at Publisher · View at Google Scholar
  • Harald Breivik, Torsten Gordh, and Stephen Butler, “Keeping an open mind: Achieving balance between too liberal and too restrictive prescription of opioids for chronic non-cancer pain: Using a two-edged sword,” Scandinavian Journal of Pain, vol. 3, no. 1, pp. 1–4, 2012. View at Publisher · View at Google Scholar
  • Alessandra Rocco, Flaminia Coluzzi, Ilenia Mandatori, and Consalvo Mattia, “Non-analgesic effects of opioids: Opioid-induced nausea and vomiting: Mechanisms and strategies for their limitation,” Current Pharmaceutical Design, vol. 18, no. 37, pp. 6043–6052, 2012. View at Publisher · View at Google Scholar
  • Lynn R. Webster, “Risk Mitigation Strategies,” Controlled Substance Management in Chronic Pain, pp. 163–180, 2016. View at Publisher · View at Google Scholar
  • Mikiko Y. Takeda, Joanna G. Katzman, Ernest Dole, Melissa Heinz Bennett, Amal Alchbli, Daniel Duhigg, and Howard Yonas, “Co-prescription of Naloxone as a Universal Precautions Model for Patients on Chronic Opioid Therapy – Observational Study,” Substance Abuse, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Yaping Chang, Kan Lun Zhu, Ivan D. Florez, Sung Min Cho, Reza Donald Mirza, Norman Buckley, Jason W. Busse, Nasim Zamir, Augustin Toma, and Gordon H. Guyatt, “Attitudes toward the canadian guideline for safe and effective use of opioids for chronic non-cancer pain: A qualitative study,” Journal of Opioid Management, vol. 12, no. 6, pp. 377–387, 2016. View at Publisher · View at Google Scholar